Enhanced VAccines DEsign against antimicrobial REsistance
Sector: Hospital • Location: Italy, Ireland, United Kingdom, Spain, Germany, Hungary, Denmark, France, Romania
Source: EU Funding & Tenders Portal
EVADERE (Enhanced VAccines DEsign against antimicrobial REsistance) is a multidisciplinary consortium of 14 interna-tionally recognised experts (12 from academia and 2 from industry) from 9 European countries who will provide 15 doctor-al candidates (DCs) with high-quality inter-sectoral training in discovery and development of vaccines targeting antimicro-bial resistance (AMR) based on innovative
- Status
- Prospective
- Sector
- Hospital, Education, Government
- Location
- Italy
- Updated
- 22 Jul 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Enhanced VAccines DEsign against antimicrobial REsistance
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | forthcoming |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | EVADERE (Enhanced VAccines DEsign against antimicrobial REsistance) is a multidisciplinary consortium of 14 interna-tionally recognised experts (12 from academia and 2 from industry) from 9 European countries who will provide 15 doctor-al candidates (DCs) with high-quality inter-sectoral training in discovery and development of vaccines targeting antimicro-bial resistance (AMR) based on innovative antigens, adjuvants, and delivery methods. Trainees will acquire a broad range of transferable skills to underpin their resilience for future careers in vaccine research within academia and industry respecting gender and equality. |
Location
Country | Italy |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Hospital, Education, Government |
Article published date | 2025-10-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project